Correlation Between Acumen Pharmaceuticals and Dowlais Group

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Acumen Pharmaceuticals and Dowlais Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acumen Pharmaceuticals and Dowlais Group into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acumen Pharmaceuticals and Dowlais Group plc, you can compare the effects of market volatilities on Acumen Pharmaceuticals and Dowlais Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acumen Pharmaceuticals with a short position of Dowlais Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acumen Pharmaceuticals and Dowlais Group.

Diversification Opportunities for Acumen Pharmaceuticals and Dowlais Group

AcumenDowlaisDiversified AwayAcumenDowlaisDiversified Away100%
-0.9
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Acumen and Dowlais is -0.9. Overlapping area represents the amount of risk that can be diversified away by holding Acumen Pharmaceuticals and Dowlais Group plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dowlais Group plc and Acumen Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acumen Pharmaceuticals are associated (or correlated) with Dowlais Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dowlais Group plc has no effect on the direction of Acumen Pharmaceuticals i.e., Acumen Pharmaceuticals and Dowlais Group go up and down completely randomly.

Pair Corralation between Acumen Pharmaceuticals and Dowlais Group

Given the investment horizon of 90 days Acumen Pharmaceuticals is expected to under-perform the Dowlais Group. In addition to that, Acumen Pharmaceuticals is 1.84 times more volatile than Dowlais Group plc. It trades about -0.09 of its total potential returns per unit of risk. Dowlais Group plc is currently generating about -0.01 per unit of volatility. If you would invest  104.00  in Dowlais Group plc on December 2, 2024 and sell it today you would lose (14.00) from holding Dowlais Group plc or give up 13.46% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Acumen Pharmaceuticals  vs.  Dowlais Group plc

 Performance 
JavaScript chart by amCharts 3.21.15Dec2025Feb -40-2002040
JavaScript chart by amCharts 3.21.15ABOS DWLAF
       Timeline  
Acumen Pharmaceuticals 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Acumen Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
JavaScript chart by amCharts 3.21.15JanFebFebMar1.41.61.822.22.4
Dowlais Group plc 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Dowlais Group plc are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, Dowlais Group reported solid returns over the last few months and may actually be approaching a breakup point.
JavaScript chart by amCharts 3.21.15JanFebFebMar0.750.80.850.9

Acumen Pharmaceuticals and Dowlais Group Volatility Contrast

   Predicted Return Density   
JavaScript chart by amCharts 3.21.15-6.54-4.9-3.26-1.610.02191.312.633.945.25 0.0250.0300.0350.0400.0450.050
JavaScript chart by amCharts 3.21.15ABOS DWLAF
       Returns  

Pair Trading with Acumen Pharmaceuticals and Dowlais Group

The main advantage of trading using opposite Acumen Pharmaceuticals and Dowlais Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acumen Pharmaceuticals position performs unexpectedly, Dowlais Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dowlais Group will offset losses from the drop in Dowlais Group's long position.
The idea behind Acumen Pharmaceuticals and Dowlais Group plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Commodity Directory
Find actively traded commodities issued by global exchanges
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account